Cargando…
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
The endocannabinoid system (ECS) has lately been proven to be an important, multifaceted homeostatic regulator, which influences a wide-variety of physiological processes all over the body. Its members, the endocannabinoids (eCBs; e.g., anandamide), the eCB-responsive receptors (e.g., CB(1), CB(2)),...
Autores principales: | Tóth, Kinga Fanni, Ádám, Dorottya, Bíró, Tamás, Oláh, Attila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429381/ https://www.ncbi.nlm.nih.gov/pubmed/30845666 http://dx.doi.org/10.3390/molecules24050918 |
Ejemplares similares
-
Opioidergic Signaling—A Neglected, Yet Potentially Important Player in Atopic Dermatitis
por: Ádám, Dorottya, et al.
Publicado: (2022) -
Targeting Cutaneous Cannabinoid Signaling in Inflammation - A “High”-way to Heal?
por: Oláh, Attila, et al.
Publicado: (2017) -
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
por: Oláh, Attila, et al.
Publicado: (2017) -
Anandamide Concentration-Dependently Modulates Toll-Like Receptor 3 Agonism or UVB-Induced Inflammatory Response of Human Corneal Epithelial Cells
por: Angyal, Ágnes, et al.
Publicado: (2021) -
Nicotinic acid suppresses sebaceous lipogenesis of human sebocytes via activating hydroxycarboxylic acid receptor 2 (HCA(2))
por: Markovics, Arnold, et al.
Publicado: (2019)